Lajos G.
- Country
- Hungary
- Department
- Gyógyszerterápiás Központ, Urogenitális Tumorok és Klinikai Farmakológiai Osztály, Kemoterápia C”
Research Overview
- Pharmacokinetic Study of MK-3475A in Patients with Advanced or Metastatic Solid Tumors
- A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-641)
- Phase 3 Study of Vepugratinib and Combination Therapy in Adults with Untreated FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma
Data & Insights
Has run more than one trial at 303 of 568 partner sites.
Specializations
Urological Oncology
The investigator specializes in treating advanced forms of urothelial carcinoma and evaluating novel therapeutic approaches involving targeted therapies like HER2-directed treatments.
- Advanced Urothelial Cancer
- HER2-expressing Bladder Cancer
- Locally Advanced Urothelial Disease
Prostate Cancer Research
Focuses on advanced prostate cancer treatments, particularly metastatic castration-resistant prostate cancer and castration-sensitive prostate cancer, exploring combination therapies.
- Hormonal Therapy Combinations
- Novel Treatment Approaches
- Biochemically Recurrent Disease
Kidney Cancer Treatment
Dedicated to advancing treatment options for renal cell carcinoma, including both clear cell and non-clear cell variants, with expertise in targeted and immunotherapy approaches.
- Advanced Renal Cell Carcinoma
- First-line Therapy Development
- Combination Treatment Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.